die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1399
2
1
gregorian
2020
5
1
9
1
online
1
fulltext
en
Evaluation of the Epigenetic Demethylation of NRF2, a Master Transcription Factor for Antioxidant Enzymes, in Colorectal Cancer
زیست شناسی ملکولی
Molecular Biology
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong><em>Background:</em></strong> Epigenetic changes in CpG islands of the promoter regions of homeostasis-related genes, including nuclear factor erythroid 2-related factor 2 (<em>NRF2</em>), have been shown to hold a significant role in the development of colorectal cancer. Therefore, we aimed to examine the DNA demethylation pattern of the <em>NRF2</em> promoter region in cancerous lesions from patients with colorectal cancer and the association of methylation status with clinicopathological features in the Iranian population.<br>
<br>
<strong><em>Methods:</em></strong> In this cross-sectional study, 114 colorectal tissue samples were collected. These samples included: 34 tumour tissue samples, 60 precancerous polyps, and 20 normal tissue samples. The promoter methylation status of the <em>NRF2</em> gene was examined using methylation-specific PCR. Additionally, the relationship between the methylation status and the clinicopathological features was investigated.<br>
<br>
<strong><em>Results</em></strong><strong><em>:</em></strong> The frequency of <em>NRF2</em> demethylation in the tumour samples was significantly higher compared to the polyp tissues (p= 0.003) and normal tissue (p= 0.009), indicating that cancerous colorectal tissues exhibit increased demethylation of the <em>NRF2</em> promoter. After examining the demethylation status of tissue samples, the clinicopathological features were compared to the demethylation results. No significant association was found between <em>NRF2</em> promoter demethylation and the clinicopathological features of patient samples.<br>
<br>
<strong><em>Conclusions: </em></strong>Our findings suggest that the epigenetic modifications leading to <em>NRF2 </em>demethylation found in colorectal tumour samples may contribute to cancer progression from precancerous polyps to cancerous lesions.</div>
Colorectal Cancer, Epigenetic, Methylation-specific PCR, NRF2.
33
39
http://rbmb.net/browse.php?a_code=A-10-313-2&slc_lang=en&sid=1
Zahra
Taheri
zahra_taheri_2005@yahoo.com
100319475328460017489
100319475328460017489
No
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Hamid
Asadzadeh Aghdaei
hamid.assadzadeh@gmail.com.
100319475328460017490
100319475328460017490
No
Basic and Molecular Epidemiology of Gastroenterology Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Shiva
Irani
shi_irani@yahoo.com
100319475328460017491
100319475328460017491
Yes
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mohammad Hossein
Modarressi
modaresi@tums.ac.ir
100319475328460017492
100319475328460017492
No
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Zahra
Noormohammadi
marjannm@yahoo.com
100319475328460017493
100319475328460017493
No
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.